25 June 2024
Update on ADJUVANT BR.31 Phase III trial of Imfinzi in non-small cell lung cancer High-level results from the ADJUVANT BR.31 Phase III trial, sponsored by the Canadian Cancer Trials…
Anpario plc (“Anpario”, “Group” or the “Company”) AGM Statement Anpario plc, the independent manufacturer of natural sustainable animal feed additives for health, nutrition and…
Wynnstay Group Plc (“Wynnstay” or the “Group” or the “Company”) Interim Results for the six months ended 30 April 2024 Performance affected by challenging…
24 June 2024
Launch of US$2 billion share buyback programme HKEx English versionHKEx Chinese versionLSE Launch of US$2 billion share buyback programme1 CEO Anil Wadhwani, said: “I am…
20 June 2024
Harworth Group plc (“Harworth” or “the Group”) Harworth completes sale of 16-acre residential land parcel to Taylor Wimpey at its mixed-use Ironbridge development Harworth…
Concurrent Technologies Plc (the “Company” or the “Group”) Concurrent Technologies announces its largest single contract win Concurrent Technologies Plc (AIM: CNC), a designer and manufacturer…
Sale of core banking business to NatWest Group Further to its announcement on 18 January 2024 regarding a phased withdrawal from its core banking…
19 June 2024
Year End Trading Update Games Workshop is pleased to announce that for the 53 weeks ended 2 June 2024, we estimate the Group’s core…